BOSUTINIB FOR CHRONIC PHASE CHRONIC MYELOID LEUKEMIA AFTER IMATINIB FAILURE: ≥8-YEAR UPDATE OF A PHASE 1/2 STUDY

EHA Library, Jorge Cortes, 294684

LONG-TERM OUTCOMES OF TYROSINE KINASE INHIBITOR IN THIRD-LINE THERAPY OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS

EHA Library, Tamara Chitanava, 294685

CLINICAL IMPACTS OF GERMLINE AND SOMATIC DDX41 MUTATIONS ON MYELOID NEOPLASMS.

EHA Library, Hideki Makishima, 294686

MODULATION OF THE IL-6/STAT3 SIGNALING AXIS IN CD4+ T CELLS REPRESENTS A IMMUNE-MEDIATED MECHANISM OF ACTION OF AZACYTIDINE IN HIGH-RISK MYELODYSPLASTIC SYNDROMES

EHA Library, Ioannis Kotsianidis, 294687

LOSS OF INTRON RETENTION INDUCES LOSS OF R-LOOPS AND REPLICATION STRESS IN SF3B1-MUTATED ERYTHROBLASTS

EHA Library, Carine Lefèvre, 294688

IN VITRO AND IN VIVO PRECLINICAL MODELS FOR TESTING NEW THERAPIES FOR AZACITIDINE-RESISTANT MDS/AML.

EHA Library, Tomas Stopka, 294690

KINETIC PROFILING IDENTIFIES AGE- AND MDS- RELATED CHANGES IN HEMATOPOIETIC STEM AND PROGENITOR CELL DYNAMICS

EHA Library, Michele Buck, 294691

DISTINCT ETHNIC, CLINICAL, AND GENETIC CHARACTERISTICS OF DER(1;7) IN MYELODYSPLASTIC SYNDROMES.

EHA Library, Rurika Okuda, 294692

THE IMPACT OF MICROMEGAKARYOCYTES ON THE MYELODYSPLASTIC SYNDROMES PROGNOSIS

EHA Library, SILVIA SAUMELL, 294693

EFFECT OF LUSPATERCEPT (RAP-536) ON MDS PDX-MURINE MODELS WITH OR WITHOUT SF3B1 MUTATION

EHA Library, Mathieu Meunier, 294694

EVALUATING PATHOGENICITY OF RUNX1 VARIANTS OF UNCERTAIN SIGNIFICANCE BY APPLYING FUNCTIONAL ASSAYS ADDRESSING DIFFERENT MOLECULAR ASPECTS OF THE RUNX1:CBFΒ TRANSCRIPTION FACTOR COMPLEX

EHA Library, Tim Ripperger, 294695

PROMOTER CHROMATIN STATE TRANSITIONS AND TRANSCRIPTIONAL ACTIVITY IN ASXL1-MUTANT CHRONIC MYELOMONOCYTIC LEUKEMIA

EHA Library, Moritz Binder, 294696

LOW IGF1 SIGNALING IN MYELODYSPLASTIC CD34+ HSC IS ASSOCIATED WITH A LEUKEMIC STEM CELL SIGNATURE, REDUCED PROLIFERATIVE ACTIVITY AND POOR PROGNOSIS

EHA Library, Thomas Luft, 294697

INHIBITION OF GLYCOLYSIS IN MYELODYSPLASTIC SYNDROME (MDS): A NOVEL STRATEGY FOR NEW APPROACH FOR THE TARGETED THERAPY OF MDS

EHA Library, Seiichi Okabe, 294698

KER-050, A NOVEL MODIFIED ACTRIIA LIGAND TRAP, INCREASES RED BLOOD CELL PRODUCTION IN CYNOMOLGUS MONKEYS

EHA Library, KEITH BABBS, 294699

IMPACT OF RAS-PATHWAY ACTIVATION ON PHENOTYPE AND OUTCOME IN PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA AND A TET2/SRSF2 COMUTATION

EHA Library, Klaus Geissler, 294700

UPREGULATED HIF-1Α EXPRESSION IN HIGH RISK MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA PATIENTS IS ASSOCIATED WITH BETTER RESPONSE TO AZACITIDINE - DATA FROM THE HELLENIC MDS STUDY GROUP

EHA Library, Vasiliki Pappa, 294701

TP53 STATUS AND OUTCOME IN MYELODYSPLASTIC SYNDROMES WITH COMPLEX ABERRANT KARYOTYPES

EHA Library, Detlef Haase, 294702

KER-050, A NOVEL INHIBITOR OF TGFΒ SUPERFAMILY SIGNALING, INDUCES RED BLOOD CELL PRODUCTION AND IS A POTENTIAL CANDIDATE FOR THE TREATMENT OF INEFFECTIVE HEMATOPOIESIS

EHA Library, Marina Feigenson, 294703

SEVERE ERYTHROID LINEAGE FAILURE DISCRIMINATES RESPONSE AND PROGNOSIS IN MYELODYSPLASTIC SYNDROMES

EHA Library, Huijun Huang, 294704

ATYPICAL DELETIONS OF THE LONG ARM OF CHROMOSOME 5 WITH RETAINED COMMONLY DELETED REGIONS (CDR) IN MDS

EHA Library, Zuzana Zemanova, 294705

BIOENERGETIC ALTERATIONS AS DEFINING FEATURES OF LOW VERSUS HIGH RISK MYELODYSPLASTIC SYNDROMES

EHA Library, Aikaterini Poulaki, 294706

CD3+CD56+ CELLS (TR3-56) AND IMMUNE TOLERANCE CONTROL IN THE BONE MARROW (BM) OF MYELODYSPLASTYC SYNDROME (MDS) INDIVIDUALS.

EHA Library, Stefania Leone, 294707

COMPARISON OF CLINICAL, GENETIC CHARACTERISTICS AND PROGNOSIS OF CMML WITH OR WITHOUT RING SIDEROBLASTS AND MYELODYSPLASTIC SYNDROMES WITH RING SIDEROBLASTS WITH OR WITHOUT MONOCYTOSIS

EHA Library, Blanca Xicoy, 294708

DEFERASIROX-DEPENDENT IRON CHELATION AFFECTS MITOCHONDRIAL DYNAMICS AND STRUCTURE AND RESTORES TP53 FAMILY MEMBERS SIGNALING

EHA Library, Cristina Panuzzo, 294709

DNA REPAIR MECHANISMS IN MYELODYSPLASTIC SYNDROMES (MDS): DIFFERENTIAL GENE EXPRESSION IN MDS SUBTYPES

EHA Library, Stamatina Roussou, 294710

MOLECULAR CHARACTERISTICS THAT PREDICT RESPONSE TO AZACITIDINE THERAPY

EHA Library, Yasuhito Nannya, 294711

THE PROGNOSTIC IMPACT OF CYTOGENETIC SCORES IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROME TREATED WITH VENETOCLAX AND AZACITIDINE IN A PHASE 1 STUDY

EHA Library, Joshua Richter, 294712

ASSESSING THE DETERMINANTS OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES

EHA Library, Igor Stojkov, 294713

MOLECULAR AND CLINICAL FEATURES OF MYELOID NEOPLASMS WITH SOMATIC DDX41 MUTATIONS

EHA Library, Zhijian Xiao, 294714

CLINICAL BENEFIT OF LUSPATERCEPT IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) AND HIGH TRANSFUSION BURDEN (HTB) IN THE PHASE 3 MEDALIST STUDY

EHA Library, Amer M. Zeidan, 294715

DIFFERENCES IN THE GENETIC LANDSCAPE BETWEEN YOUNGER AND OLDER PATIENTS WITH MYELODYSPLASTIC SYNDROME

EHA Library, Wan Hsuan Lee, 294716

COMPARISON BETWEEN UPFRONT TRANSPLANTATION AND CYTOREDUCTIVE THERAPY PRE-TRANSPLANTATION IN PATIENTS WITH MDS-EB-1 OR MDS-EB-2

EHA Library, Yili Chen, 294717

COMBINING FLOW CYTOMETRY, CYTOGENETICS AND MUTATION PROFILING IN PATIENTS WITH IDIOPATHIC CYTOPENIA: AN INTEGRATED PREDICTIVE MODEL

EHA Library, Aref Al-Kali, 294718

REAL-WORLD CLINICAL OUTCOMES IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES TREATED WITH HYPOMETHYLATING AGENTS IN THE US: A SEER-MEDICARE ANALYSIS

EHA Library, Eytan M. Stein, 294719

EVOLUTIONARY ACTION SCORE OF MISSENSE TP53 MUTATIONS (EAP53) IS AN INDEPENDENT PREDICTOR OF SURVIVAL IN MYELODYSPLASTIC SYNDROMES

EHA Library, Rashmi Kanagal-Shamanna, 294720

PROGNOSTIC VALUE OF MONOCYTE SUBSET DISTRIBUTION IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) : RESULTS OF A MULTICENTER STUDY.

EHA Library, Matthieu Jestin, 294721

PROSPECTIVE EVALUATION FOR MYELOID CLONAL EVOLUTION AND ADVERSE CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CLONAL CYTOPENIAS OF UNDETERMINED SIGNIFICANCE (CCUS)

EHA Library, Marissa Li, 294722

ADMINISTRATION OF KER-050, A NOVEL ACTRIIA LIGAND TRAP, TO HEALTHY PARTICIPANTS ELICITED ROBUST AND SUSTAINED INCREASES IN HEMOGLOBIN AND PLATELETS

EHA Library, CLAUDIA ORDONEZ, 294723

EFFECTS OF LUSPATERCEPT ON SERUM FERRITIN IN PATIENTS (PTS) WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (MDS) WITH RING SIDEROBLASTS (RS) IN THE PHASE 3 MEDALIST TRIAL

EHA Library, Pierre Fenaux, 294724

DEVELOPMENT OF GUIDELINE-BASED INDICATORS FOR ADULT PATIENTS WITH MYELODYSPLASTIC SYNDROMES

EHA Library, Nicolas Bonadies, 294725

MOLECULAR BASIS AND CLINICAL IMPLICATION OF SPONTANEOUS IN VITRO MYELOID COLONY FORMATION IN CHRONIC MYELOMONOCYTIC LEUKEMIA

EHA Library, Klaus Geissler, 294726

ROLE AND RATE OF ALLOGENEIC STEM CELL TRANSPLANTATION IN MYELODYSPLASTIC SYNDROMES: DATA FROM THE FISIM REGISTRY

EHA Library, Elena Crisà, 294727

PRACINOSTAT LOWER DOSE PLUS AZACITIDINE SAFETY AND EFFICACY IN PATIENTS WITH HIGH/VERY HIGH-RISK MYELODYSPLASTIC SYNDROMES: A PHASE II STUDY

EHA Library, Michael K. Keng, 294728

ASSESSMENT OF DOSE-DEPENDENT RESPONSE TO LUSPATERCEPT IN PATIENTS (PTS) WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) WITH RING SIDEROBLASTS IN THE PHASE 3 MEDALIST TRIAL

EHA Library, Uwe Platzbecker, 294729

LONGER-TERM RED BLOOD CELL (RBC) TRANSFUSION REDUCTION IN THE PHASE 3 MEDALIST STUDY OF LUSPATERCEPT IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) WITH RING SIDEROBLASTS (RS)

EHA Library, Rami S. Komrokji, 294730

SIGNIFICANT RATE OF PATIENTS WITH MYELODYSPLASTIC SYNDROME FAILING TO REACH ALLOGENIC STEM CELL TRANSPLANTATION: A POPULATION -BASED STUDY

EHA Library, Carolin Lindholm, 294731

PRELIMINARY RESULTS FROM AN OPEN-LABEL, PHASE 2 STUDY OF TIPIFARNIB IN CHRONIC MYELOMONOCYTIC LEUKEMIA, (CMML) AND OTHER MYELODYSPLASTIC /MYELOPROLIFERATIVE NEOPLASIAS (MDS/MPN).

EHA Library, Dr. Mrinal Patnaik, 294732

IMPACT OF ERYTHROPOIETIN STIMULATION AGENTS AND RED BLOOD CELL TRANSFUSION ON HEALTH-RELATED QUALITY OF LIFE IN LOWER-RISK MYELODYSPLASTIC SYNDROME

EHA Library, Hege Gravdahl Garelius, 294733

CONSENSUS SET OF CORE PATIENT-REPORTED OUTCOMES FOR MYELODYSPLASTIC SYNDROMES DEFINED BY PATIENTS AND HEMATOLOGISTS – EUMDS REGISTRY GROUP STUDY

EHA Library, Igor Stojkov, 294734

CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA WHO DEVELOPED THERAPY RELATED MYELOID NEOPLASMS FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION

EHA Library, Fevzi Yalniz, 294735

AZACITIDINE AND LENALIDOMIDE (COMBINED VERSUS SEQUENTIAL TREATMENT) IN HIGHER-RISK MYELODYSPLASTIC SYNDROMES. FINAL RESULTS OF A RANDOMIZED PHASE II MULTICENTER STUDY AND LONG-LASTING RESPONSES

EHA Library, Carlo Finelli, 294736

FACTORS ASSOCIATED WITH RISK OF CARDIOVASCULAR DEATH IN MDS. A NESTED CASE CONTROL STUDY OF 831 PATIENTS OF THE HELLENIC NATIONAL REGISTRY OF MYELODYSPLASTIC AND HYPOPLASTIC SYNDROMES.

EHA Library, Ioannis Kotsianidis, 294737

CUMULATIVE LINES OF PRIOR CHEMOTHERAPY PREDICT OVERALL SURVIVAL IN THERAPY-RELATED MYELODYSPLASTIC SYNDROME (MDS)

EHA Library, Urshila Durani, 294738

THE PROGNOSTIC IMPACT OF MEDULLARY ABNORMALITIES OF THE APPENDICULAR SKELETON DETECTED BY LOW-DOSE MULTIDETECTOR COMPUTED TOMOGRAPHY AND WILMS' TUMOR GENE 1 EXPRESSION LEVELS IN PATIENTS WITH MDS

EHA Library, Kentaro Narita, 294739

CLINICAL ANALYSIS OF GENE MUTATION CHARACTERISTICS AND MUTATION BURDEN IN MYELODYSPLASTIC SYNDROME

EHA Library, xiaodong lyu, 294740

EFFECT OF AZACYTIDINE ON SURVIVAL AND LEUKEMIA EVOLUTION IN INTERMEDIATE-RISK MDS: A RETROSPECTIVE COHORT ANALYSIS OF THE HELLENIC NATIONAL REGISTRY OF MYELODYSPLASTIC AND HYPOPLASTIC SYNDROMES.

EHA Library, Ioannis Kotsianidis, 294741

NATURAL HISTORY OF LOWER-RISK MYELODYSPLASTIC SYNDROMES WITH RING SIDEROBLASTS: A RETROSPECTIVE ANALYSIS OF THE CANADIAN MDS-CAN REGISTRY

EHA Library, Heather Leitch, 294742

IVOSIDENIB (IVO) IN PATIENTS WITH IDH1-MUTANT RELAPSED/REFRACTORY MYELODYSPLASTIC SYNDROME (R/R MDS): UPDATED ENROLLMENT OF A PHASE 1 DOSE ESCALATION AND EXPANSION STUDY

EHA Library, Courtney D DiNardo, 294743

THE BURDEN OF RED BLOOD CELL TRANSFUSIONS ON OVERALL SURVIVAL, HEALTHCARE RESOURCE UTILIZATION, AND QUALITY OF LIFE IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES AND RING SIDEROBLASTS

EHA Library, Heather Leitch, 294744

POST-TRANSPLANT OUTCOMES OF PATIENTS WITH MDS AND AML AFTER RECEIVING HYPOMETHYLATING AGENT THERAPY COMBINED WITH THE TIM-3 INHIBITOR, MBG453

EHA Library, Andrew Brunner, 294745

MUTATIONS IN RAS PATHWAY GENES CORRELATE WITH TYPE OF FAILURE TO AZACITIDINE: GENOMIC ANALYSIS AT RANDOMIZATION ONTO THE INSPIRE TRIAL

EHA Library, Koichi Takahashi, 294746

CIRCULATING CONCENTRATIONS OF HMGB1 IN PATIENTS WITH MYELODYSPLASTIC SYNDROME: EXPLORATORY STUDY

EHA Library, Elia Apodaca, 294747

MDS IRON ROAD: AN INTERNET-BASED ALGORITHM FOR THE DIAGNOSIS, WORKUP AND MANAGEMENT OF IRON OVERLOAD (IOL) IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) FROM THE CANADIAN CONSORTIUM ON MDS (CCMDS)

EHA Library, Heather Leitch, 294748

ESTIMATED GLOMERULAR FILTRATION RATE INDEPENDENTLY PREDICTS OUTCOME OF AZACYTIDINE THERAPY IN MDS. RESULTS FROM THE HELLENIC NATIONAL REGISTRY OF MYELODYSPLASTIC AND HYPOPLASTIC SYNDROMES.

EHA Library, Ioannis Kotsianidis, 294749

A THREE-PARAMETER SCORE BASED ON BONE MARROW IMMUNOPHENOTYPING IS COMPLEMENTARY TO IPSS-R FOR PROGNOSIS OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES.

EHA Library, Irene Lorand-Metze, 294750

TRANSFORMATION FROM MYELODYSPLASTIC SYNDROME AND RESEMBLES, IDIOPATHIC CYTOPENIA AND CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE, TO ACUTE MYELOID LEUKEMIA.

EHA Library, Volkan Bas, 294751

A RANDOMIZED, CROSSOVER STUDY TO EVALUATE THE EFFECTS OF PEVONEDISTAT ON THE QTC INTERVAL IN PATIENTS WITH ADVANCED MALIGNANCIES

EHA Library, Xiaofei Zhou, 294752

INTERIM RESULTS FROM AN ONGOING PHASE 1/2 CLINICAL TRIAL OF TAGRAXOFUSP (SL-401), A CD123-DIRECTED THERAPY, IN PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)

EHA Library, Mrinal M. Patnaik, 294753

DIACYLGLYCEROL KINASE Z DEFICIENCY TRIGGERS EARLY SIGNS OF APLASTIC ANEMIA IN MICE

EHA Library, Miguel Martin Salgado, 294754

UM171 STIMUALTES THE HEMATOPOIETIC DIFFERENTIATION OF HUMAN INDUCED PLURIPOTENT STEM CELLS OF PATIENTS WITH APLASTIC ANEMIA

EHA Library, Maria Florencia Tellechea, 294755

STUDY OF MOLECULAR, FLOW-CYTOMETRIC CHARACTERISTICS AND LONG-TERM OUTCOME OF PATIENTS WITH IDIOPATHIC CYTOPENIA OF UNDETERMINED SIGNIFICANCE AND ISOLATED NEUTROPENIA (ICUS-N)

EHA Library, Stavros Papadakis, 294756

THE ROLE OF DECREASED TIM3 EXPRESSION OF NK CELLS IN THE IMMUNE PATHOGENESIS OF SEVERE APLASTIC ANEMIA

EHA Library, Shaoxue Ding, 294757

A ZEBRAFISH MODEL FOR SEVERE CONGENITAL NEUTROPENIA WITH HAX1 DEFICIENCY

EHA Library, Narges Aghaallaei, 294758

LONG NON-CODING RNA FAM157C CONTRIBUTED TO THE PROLIFERATION OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA CLONES

EHA Library, Rong Fu, 294759

PHENOTYPIC CHANGES CAUSED BY NOVEL SNV OF RPS7 GENE

EHA Library, AGATA KUBICKOVA, 294760

CELLULAR AND MOLECULAR MECHANISMS UNDERLYING THE ALTERED IN VITRO CAPILLARY-LIKE CAPABILITY OF SHWACHMAN-DIAMOND SYNDROME MESENCHYMAL STROMAL CELLS

EHA Library, Gloria Bedini, 294761

DEVELOPMENT OF A COMPOSITE ENDPOINT TO EVALUATE TREATMENT BENEFIT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Austin Kulasekararaj, 294762

WHOLE GENOME SEQUENCING REVEALS BROAD DIAGNOSTIC HETEROGENEITY IN PATIENTS WITH FEATURES RESEMBLING DIAMOND-BLACKFAN ANAEMIA

EHA Library, Josu de la Fuente, 294763

LANDSCAPE OF GENETIC VARIATIONS IN A COHORT OF CHILDREN WITH BONE MARROW FAILURE (BMF) USING A TARGETED NEXT GENERATION SEQUENCING (NGS) APPROACH

EHA Library, Prashant Chhabra, 294764

STROMAL PRECURSORS IN THE BONE MARROW OF UNTREATED APLASTIC ANEMIA PATIENTS

EHA Library, Alena Dorofeeva, 294765

THE ROLE OF LNCRNA-AF117829.1 IN THE IMMUNOPATHOGENESIS OF CD8+ T CELLS IN PATIENTS WITH SEVERE APLASTIC ANEMIA

EHA Library, Rong Fu, 294767

OUTCOMES OF PATIENTS WITH MONOSOMY 7 EVOLVED FROM SEVERE APLASTIC ANEMIA: TRANSPLANT VERSUS CHEMOTHERAPY AND SUPPORTIVE CARE

EHA Library, Emma Groarke, 294768

ORAL CXCR4 ANTAGONIST MAVORIXAFOR TREATMENT IN PATIENTS WITH WHIM SYNDROME: RESULTS OF AN OPEN LABEL PHASE 2 STUDY WITH LONG-TERM EXTENSION.

EHA Library, Sarah Cohen, 294769

EFFECTIVENESS OF ECULIZUMAB TREATMENT IN PATIENTS AGED ≥ 65 YEARS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH): RESULTS FROM THE INTERNATIONAL PNH REGISTRY

EHA Library, Jong Wook Lee, 294770

EFFECTS OF AN L-LEUCINE ADMINISTRATION IN DIAMOND-BLACKFAN ANEMIA PATIENTS

EHA Library, Dagmar Pospisilova, 294771

EFFECTS OF ORAL, FACTOR D INHIBITOR DANICOPAN ON TRANSFUSION RATES IN TRANSFUSION DEPENDENT PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) PATIENTS WITH A SUB-OPTIMAL RESPONSE TO ECULIZUMAB: PHASE 2 STUDY

EHA Library, Austin Kulasekararaj, 294772

HIGH-DOSE ROMIPLOSTIM ACCELERATES HEMATOLOGIC RECOVERY IN PATIENTS WITH APLASTIC ANEMIA REFRACTORY TO ELTROMBOPAG

EHA Library, Kohei Hosokawa, 294774

FLUDARABINE ALLOWS REDUCTION IN CONDITIONING INTENSITY TO ABROGATE THE INCREASED RISK OF GUT AND LUNG TOXICITY IN TRANSPLANTATION FOR DIAMOND BLACKFAN ANAEMIA WITHOUT IMPACT IN CHIMERISM STATUS

EHA Library, Josu de la Fuente, 294775

NEXT-GENERATION SEQUENCING GENE-PANELS FOR THE DETECTION OF TRANSFORMATION TO MDS/AML IN CHILDREN AND YOUNG ADULTS WITH ACQUIRED OR INHERITED CYTOPENIAS

EHA Library, Orna Steinberg Shemer, 294776

POZELIMAB INHIBITS HEMOLYSIS IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)

EHA Library, Jun-Ho Jang, 294777

INFECTIONS DURING ECULIZUMAB THERAPY IN A DUTCH POPULATION OF PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Charlotte Schaap, 294778

AN INTERIM ANALYSIS OF A PHASE 2 STUDY EVALUATING THE EFFICACY, SAFETY AND PHARMACOKINETICS OF INTRAVENOUS RAVULIZUMAB 100 MG/ML FORMULATION IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Alexander Röth, 294779

AN OPTIMIZED DOSING STRATEGY FOR CROVALIMAB IN TREATMENT OF COMPLEMENT-INHIBITOR-NAIVE OR -EXPERIENCED PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)

EHA Library, Julia Ramos, 294780

CYTOKINE PROFILE IN NEWLY DIAGNOSED CASES OF APLASTIC ANEMIA AND ITS CORRELATION WITH THE SEVERITY AND TREATMENT OUTCOMES IN APLASTIC ANEMIA

EHA Library, Rahul Vatsayan, 294781

CLINICAL AND MOLECULAR CHARACTERISTICS OF CHILDREN WITH SEVERE CHRONIC NEUTROPENIA: A SINGLE CENTER EXPERIENCE IN ARGENTINA

EHA Library, Maria Florencia Mininni, 294782

USE OF PROPHYLACTIC ANTIBIOTICS IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATED WITH ECULIZUMAB

EHA Library, Christopher J. Patriquin, 294783

LOW PLASMA HAPTOGLOBIN AND ENDOTHELIAL INJURY IN HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

EHA Library, Jon Badiola, 294784

SEX HORMONE LEVELS, TELOMERE LENGTH, AND EXPRESSION OF POTENTIAL REGULATORY SITES OF SEX HORMONE-TELOMERE IN PATIENTS WITH CHRONIC ACQUIRED APLASTIC ANEMIA

EHA Library, Ruirong Xu, 294785

REVEALING TRANSCRIPTOME DEREGULATION UPON GENOMIC COMPLEXITY IN MULTIPLE MYELOMA.

EHA Library, Bachisio Ziccheddu, 294786